Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 85 of 1,261
  1. US 12129258

    Diaryl macrocyclic compound and pharmaceutical composition, and use thereof

    PrimeGene (Beijing) Co., Ltd. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  2. US 12129467

    Non-liposomal systems for nucleic acid delivery

    ARBUTUS BIOPHARMA CORPORATION Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  3. US 12129471

    Materials and methods for treatment of human genetic diseases including hemoglobinopathies

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  4. US 12128102

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  5. US 12129307

    HER-2 binding antibodies

    MAB Discovery GmbH Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  6. US 12129263

    Kinase inhibitors and uses thereof

    DENALI THERAPEUTICS INC. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  7. US 12128122

    Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

    Krystal Biotech, Inc. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  8. US 12128036

    Compositions and methods for storage stable ophthalmic drugs

    LENZ THERAPEUTICS OPERATIONS, INC. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  9. US 12128034

    Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

    Iterum Therapeutics International Limited Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  10. US 12128048

    Combination therapies using PRMT5 inhibitors for the treatment of cancer

    Mirati Therapeutics, Inc. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  11. US 12128044

    Fused tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  12. US 12129288

    Polynucleotides heterodimers of soluble interferon receptors and uses thereof

    Sanabio, LLC Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  13. US 12128015

    APE/REF1 inhibitors for the treatment of cancer

    The Regents of the University of California Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  14. US 12128013

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  15. US 12128090

    Methods of prophylactic treatment using recombinant VWF (rVWF)

    Takeda Pharmaceutical Company Limited Β· Granted Oct 29, 2024 Β· Expires Oct 24, 2044

    granted
  16. WO 2024219427

    PROCÉDÉ DE PRODUCTION DE LYMPHOCYTES INNÉS DE TYPE 2

    UNIV KYOTO [JP] Β· Granted Oct 24, 2024 Β· Expires Oct 19, 2044

    granted
  17. US 12123015

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  18. US 12121525

    Methods for treating GI syndrome and graft versus host disease

    The Board of Regents of the University of Texas System Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  19. US 12121569

    Methods and compositions for CNS delivery of iduronate-2-sulfatase

    Takeda Pharmaceutical Company Limited Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  20. US 12121580

    Antibacterial photodynamic therapy using copper-cysteamine nanoparticles

    The Board of Regents of the University of Texas System Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  21. US 12121503

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  22. US 12121532

    Modified antisense oligomers for exon inclusion in spinal muscular atrophy

    Sarepta Therapeutics, Inc. Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  23. US 12121288

    Combination tumor treatment

    Regents of the University of Minnesota Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted
  24. US 12121542

    BCMA chimeric antigen receptor based on single domain antibody and use thereof

    SHENZHEN PREGENE BIOPHARMA CO., LTD. Β· Granted Oct 22, 2024 Β· Expires Oct 17, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.